NeuroPace (NPCE) Enterprise Value (2020 - 2026)

NeuroPace's Enterprise Value history runs 7 years deep, the most recent figure standing at -$54.0 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 18.53% year-over-year to -$54.0 million; the TTM figure through Mar 2026 stood at -$54.0 million (up 18.53% YoY), while the FY2025 annual figure was -$61.1 million, down 15.74% from the prior year.
• Enterprise Value was -$54.0 million for Q1 2026 at NeuroPace, up from -$61.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$52.8 million in Q4 2024 to a low of -$103.2 million in Q1 2022.
• Historically, Enterprise Value has averaged -$67.3 million across 5 years, with a median of -$62.1 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value tumbled 237.95% in 2022, then jumped 34.47% in 2023.
• A 5-year view of Enterprise Value shows it stood at -$77.4 million in 2022, then grew by 14.15% to -$66.5 million in 2023, then grew by 20.61% to -$52.8 million in 2024, then fell by 15.74% to -$61.1 million in 2025, then climbed by 11.59% to -$54.0 million in 2026.
• The last three Enterprise Value figures came in at -$54.0 million (Q1 2026), -$61.1 million (Q4 2025), and -$60.0 million (Q3 2025), per Business Quant data.